JP5522717B2 - アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法 - Google Patents

アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法 Download PDF

Info

Publication number
JP5522717B2
JP5522717B2 JP2009174692A JP2009174692A JP5522717B2 JP 5522717 B2 JP5522717 B2 JP 5522717B2 JP 2009174692 A JP2009174692 A JP 2009174692A JP 2009174692 A JP2009174692 A JP 2009174692A JP 5522717 B2 JP5522717 B2 JP 5522717B2
Authority
JP
Japan
Prior art keywords
periostin
integrin
amount
atopic dermatitis
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009174692A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010096748A5 (enExample
JP2010096748A (ja
Inventor
賢治 出原
裕士 白石
昭一郎 太田
美穂 増岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saga University NUC
Original Assignee
Saga University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saga University NUC filed Critical Saga University NUC
Priority to JP2009174692A priority Critical patent/JP5522717B2/ja
Publication of JP2010096748A publication Critical patent/JP2010096748A/ja
Publication of JP2010096748A5 publication Critical patent/JP2010096748A5/ja
Application granted granted Critical
Publication of JP5522717B2 publication Critical patent/JP5522717B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2009174692A 2008-09-19 2009-07-27 アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法 Active JP5522717B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009174692A JP5522717B2 (ja) 2008-09-19 2009-07-27 アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008241295 2008-09-19
JP2008241295 2008-09-19
JP2009174692A JP5522717B2 (ja) 2008-09-19 2009-07-27 アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法

Publications (3)

Publication Number Publication Date
JP2010096748A JP2010096748A (ja) 2010-04-30
JP2010096748A5 JP2010096748A5 (enExample) 2011-09-22
JP5522717B2 true JP5522717B2 (ja) 2014-06-18

Family

ID=42258523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009174692A Active JP5522717B2 (ja) 2008-09-19 2009-07-27 アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法

Country Status (1)

Country Link
JP (1) JP5522717B2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10072293B2 (en) 2011-03-31 2018-09-11 The Procter And Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012001889A1 (ja) * 2010-06-28 2013-08-22 国立大学法人東北大学 Ｔｓｌｐを恒常的に高発現する細胞、及び前記細胞を利用したｔｓｌｐ調節剤のスクリーニング方法
RU2737245C2 (ru) 2010-12-16 2020-11-26 Дженентек, Инк. Способы диагностики и лечения, связанные с ингибированием тн2
JP5871228B2 (ja) 2011-10-31 2016-03-01 国立大学法人佐賀大学 慢性副鼻腔炎の検出方法
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
JP2015535807A (ja) 2012-08-15 2015-12-17 ザ プロクター アンド ギャンブルカンパニー 皮膚疾患の配列の治療に有効な皮膚活性剤を特定及び評価するためのシステム、モデル、及び方法
WO2015046451A1 (ja) * 2013-09-27 2015-04-02 株式会社アクアセラピューティクス 眼科疾患を除くペリオスチン発現に起因する疾患用医薬、およびその用途
WO2018030451A1 (ja) * 2016-08-09 2018-02-15 学校法人大阪医科薬科大学 癒着治療薬、癒着の治療方法、術後癒着マーカー、および術後癒着の罹患の可能性を試験する方法
KR102309982B1 (ko) * 2016-10-25 2021-10-12 코스맥스 주식회사 곡정초 추출물을 함유하는 아토피 피부염 개선용 피부 외용제 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3353209B2 (ja) * 1992-04-03 2002-12-03 ジェネンテク，インコーポレイテッド αｖβ３インテグリンに対する抗体
ES2299232T3 (es) * 1995-09-11 2008-05-16 La Jolla Cancer Research Foundation Moleculas que migran hacia un organo o tejido seleccionado in vivo.
AU2001258638A1 (en) * 2000-05-26 2001-12-03 Glaxo Group Limited Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
WO2002052006A1 (fr) * 2000-12-26 2002-07-04 Genox Research, Inc. Methode permettant d'examiner une maladie allergique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10072293B2 (en) 2011-03-31 2018-09-11 The Procter And Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

Also Published As

Publication number Publication date
JP2010096748A (ja) 2010-04-30

Similar Documents

Publication Publication Date Title
JP5522717B2 (ja) アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法
JP2019104754A (ja) アネキシン−１（リポコルチン１）をモジュレートすることによる自己免疫疾患の処置方法
WO2008141438A1 (en) Gabaergic modulators for treating airway conditions
KR102118631B1 (ko) 관절염 진단용 조성물 및 이를 포함하는 키트
CA2664327A1 (en) Method for detecting and treating skin disorders
JP2002516572A (ja) 組織の再生の調節
JPWO2009148184A1 (ja) 特発性間質性肺炎の検出方法
Henrot et al. Decreased CCN3 in systemic sclerosis endothelial cells contributes to impaired angiogenesis
Wewer et al. Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle
JP2010512781A (ja) Ｖｅｇｆｒの変化体ならびに妊娠関連の医学的状態の診断および処置におけるその使用
CN105873950A (zh) 用于治疗和诊断癌症的抗s100a7抗体
US20250236666A1 (en) Antibodies Against Extracellular Epitopes of Human TRPV6 Channel and their Diagnostic and Therapeutic Uses
US20250369988A1 (en) Cd146 and uses thereof as a biomarker and as a therapeutic target in the diagnosis and treatment of fibrosis
CA2074361A1 (en) Merosin, nucleic acids encoding, fragments and uses thereof
Pigors et al. Anti-laminin β4 IgG drives tissue damage in anti-p200 pemphigoid and shows interactions with laminin α3 and γ1/2 chains
JP6667437B2 (ja) 最適な体重及び血糖を維持するための新規ポリペプチドホルモンの同定
US20250134879A1 (en) Novel use of melanocortin-1 receptor agonist
CN102778566B (zh) Dlk1在肝癌诊断及预后判断中的应用
CN106075468B (zh) Gps2用于制备软组织肿瘤预后、诊断或防治的药物的用途
US20240115546A1 (en) Agent for preventing or ameliorating pruritus
JP5885243B2 (ja) 胆管細胞癌の検出方法および予防・治療剤のスクリーニング方法
Zhang et al. Increased expression of connective tissue growth factor in patients with urethral stricture
DAHLBÄCK et al. Vitronectin colocalizes with Ig deposits and C9 neoantigen in discoid lupus erythematosus and dermatitis herpetiformis, but not in bullous pemphigoid
CN112175078B (zh) 一种卵泡抑素样蛋白1的中和性抗体及其应用
JP2004315480A (ja) 前立腺疾患治療用医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110809

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110809

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130705

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130716

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140318

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140403

R150 Certificate of patent or registration of utility model

Ref document number: 5522717

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250